1. Home
  2. RAPT vs GGT Comparison

RAPT vs GGT Comparison

Compare RAPT & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • GGT
  • Stock Information
  • Founded
  • RAPT 2015
  • GGT 1994
  • Country
  • RAPT United States
  • GGT United States
  • Employees
  • RAPT N/A
  • GGT N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • GGT Trusts Except Educational Religious and Charitable
  • Sector
  • RAPT Health Care
  • GGT Finance
  • Exchange
  • RAPT Nasdaq
  • GGT Nasdaq
  • Market Cap
  • RAPT 122.9M
  • GGT 134.4M
  • IPO Year
  • RAPT 2019
  • GGT N/A
  • Fundamental
  • Price
  • RAPT $11.74
  • GGT $4.19
  • Analyst Decision
  • RAPT Buy
  • GGT
  • Analyst Count
  • RAPT 5
  • GGT 0
  • Target Price
  • RAPT $33.60
  • GGT N/A
  • AVG Volume (30 Days)
  • RAPT 105.9K
  • GGT 59.7K
  • Earning Date
  • RAPT 08-07-2025
  • GGT 01-01-0001
  • Dividend Yield
  • RAPT N/A
  • GGT 15.56%
  • EPS Growth
  • RAPT N/A
  • GGT N/A
  • EPS
  • RAPT N/A
  • GGT 0.83
  • Revenue
  • RAPT N/A
  • GGT N/A
  • Revenue This Year
  • RAPT N/A
  • GGT N/A
  • Revenue Next Year
  • RAPT N/A
  • GGT N/A
  • P/E Ratio
  • RAPT N/A
  • GGT $6.90
  • Revenue Growth
  • RAPT N/A
  • GGT N/A
  • 52 Week Low
  • RAPT $5.67
  • GGT $4.32
  • 52 Week High
  • RAPT $26.56
  • GGT $7.00
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 58.44
  • GGT 45.74
  • Support Level
  • RAPT $10.20
  • GGT $4.17
  • Resistance Level
  • RAPT $13.50
  • GGT $4.26
  • Average True Range (ATR)
  • RAPT 1.01
  • GGT 0.07
  • MACD
  • RAPT -0.05
  • GGT -0.00
  • Stochastic Oscillator
  • RAPT 77.46
  • GGT 28.57

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About GGT Gabelli Multi-Media Trust Inc. (The)

Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.

Share on Social Networks: